Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus.

Barsalou J, Costedoat-Chalumeau N, Berhanu A, Fors-Nieves C, Shah U, Brown P, Laskin CA, Morel N, Levesque K, Buyon JP, Silverman ED, Izmirly PM.

Ann Rheum Dis. 2018 Dec;77(12):1742-1749. doi: 10.1136/annrheumdis-2018-213718. Epub 2018 Oct 8.

2.

Resolution of large aortic valve vegetations in antiphospholipid syndrome treated with therapeutic anticoagulation: a report of two cases and literature review.

Yuriditsky E, Torres J, Izmirly PM, Belmont HM.

Lupus. 2018 Dec;27(14):2269-2273. doi: 10.1177/0961203318804876. Epub 2018 Oct 5. Review.

PMID:
30290716
3.

A protective Langerhans cell-keratinocyte axis that is dysfunctional in photosensitivity.

Shipman WD, Chyou S, Ramanathan A, Izmirly PM, Sharma S, Pannellini T, Dasoveanu DC, Qing X, Magro CM, Granstein RD, Lowes MA, Pamer EG, Kaplan DH, Salmon JE, Mehrara BJ, Young JW, Clancy RM, Blobel CP, Lu TT.

Sci Transl Med. 2018 Aug 15;10(454). pii: eaap9527. doi: 10.1126/scitranslmed.aap9527.

4.

The Incidence and Prevalence of Adult Primary Sjögren's Syndrome in New York County.

Izmirly PM, Buyon JP, Wan I, Belmont HM, Sahl S, Salmon JE, Askanase A, Bathon JM, Geraldino-Pardilla L, Ali Y, Ginzler EM, Putterman C, Gordon C, Helmick CG, Parton H.

Arthritis Care Res (Hoboken). 2018 Jul 25. doi: 10.1002/acr.23707. [Epub ahead of print]

PMID:
30044541
5.

The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program.

Izmirly PM, Wan I, Sahl S, Buyon JP, Belmont HM, Salmon JE, Askanase A, Bathon JM, Geraldino-Pardilla L, Ali Y, Ginzler EM, Putterman C, Gordon C, Helmick CG, Parton H.

Arthritis Rheumatol. 2017 Oct;69(10):2006-2017. doi: 10.1002/art.40192. Epub 2017 Sep 10.

6.

Clinical and pathologic implications of extending the spectrum of maternal autoantibodies reactive with ribonucleoproteins associated with cutaneous and now cardiac neonatal lupus from SSA/Ro and SSB/La to U1RNP.

Izmirly PM, Halushka MK, Rosenberg AZ, Whelton S, Rais-Bahrami K, Nath DS, Parton H, Clancy RM, Rasmussen S, Saxena A, Buyon JP.

Autoimmun Rev. 2017 Sep;16(9):980-983. doi: 10.1016/j.autrev.2017.07.013. Epub 2017 Jul 12. Review.

PMID:
28709760
7.

No histologic evidence of foetal cardiotoxicity following exposure to maternal hydroxychloroquine.

Friedman D, Lovig L, Halushka M, Clancy RM, Izmirly PM, Buyon JP.

Clin Exp Rheumatol. 2017 Sep-Oct;35(5):857-859. Epub 2017 Jun 6.

8.

Systemic Lupus Erythematosus Onset Seven Years After Initiation of Highly Active Antiretroviral Therapy in a Patient With Human Immunodeficiency Virus: Literature Review and Update on Disease Mechanism of This Unusual Presentation.

Modjinou DV, Osman JL, Haberman RH, Izmirly PM, Belmont HM.

J Clin Rheumatol. 2016 Sep;22(6):338-40. doi: 10.1097/RHU.0000000000000426. No abstract available.

PMID:
27556247
9.

In search of an antibody specificity highly predictive of congenital heart block.

Izmirly PM, Saxena A.

Lupus Sci Med. 2016 Apr 21;3(1):e000154. doi: 10.1136/lupus-2016-000154. eCollection 2016. No abstract available.

10.

Mortality in Systemic Lupus Erythematosus: an Updated Review.

Fors Nieves CE, Izmirly PM.

Curr Rheumatol Rep. 2016 Apr;18(4):21. doi: 10.1007/s11926-016-0571-2. Review.

PMID:
26984805
11.

Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system.

Izmirly PM, Saxena A, Sahl SK, Shah U, Friedman DM, Kim MY, Buyon JP.

Ann Rheum Dis. 2016 Jun;75(6):1161-5. doi: 10.1136/annrheumdis-2015-208311. Epub 2015 Dec 1.

12.

Autoimmune congenital heart block: complex and unusual situations.

Brito-Zerón P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA.

Lupus. 2016 Feb;25(2):116-28. doi: 10.1177/0961203315624024. Review.

PMID:
26762645
13.

Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.

Saxena A, Izmirly PM, Han SW, Briassouli P, Rivera TL, Zhong H, Friedman DM, Clancy RM, Buyon JP.

J Am Coll Cardiol. 2015 Aug 25;66(8):930-9. doi: 10.1016/j.jacc.2015.06.1088. Erratum in: J Am Coll Cardiol. 2015 Oct 20;66(16):1849.

14.

The clinical spectrum of autoimmune congenital heart block.

Brito-Zerón P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA.

Nat Rev Rheumatol. 2015 May;11(5):301-12. doi: 10.1038/nrrheum.2015.29. Epub 2015 Mar 24. Review.

15.

Rapid aneurysm growth and rupture in systemic lupus erythematosus.

Graffeo CS, Tanweer O, Nieves CF, Belmont HM, Izmirly PM, Becske T, Huang PP.

Surg Neurol Int. 2015 Jan 20;6:9. doi: 10.4103/2152-7806.149617. eCollection 2015.

16.

Prevention and treatment in utero of autoimmune-associated congenital heart block.

Saxena A, Izmirly PM, Mendez B, Buyon JP, Friedman DM.

Cardiol Rev. 2014 Nov-Dec;22(6):263-7. doi: 10.1097/CRD.0000000000000026. Review.

17.

Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease.

Izmirly PM, Buyon JP, Saxena A.

Curr Opin Rheumatol. 2012 Sep;24(5):466-72. doi: 10.1097/BOR.0b013e328356226b. Review.

18.

Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus.

Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, Khamashta MA, Kim MY, Saxena A, Friedman D, Llanos C, Piette JC, Buyon JP.

Circulation. 2012 Jul 3;126(1):76-82. doi: 10.1161/CIRCULATIONAHA.111.089268. Epub 2012 May 24.

19.

Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus.

Reed JH, Clancy RM, Lee KH, Saxena A, Izmirly PM, Buyon JP.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1373-81. doi: 10.1002/acr.21704.

20.

Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus.

Llanos C, Friedman DM, Saxena A, Izmirly PM, Tseng CE, Dische R, Abellar RG, Halushka M, Clancy RM, Buyon JP.

Rheumatology (Oxford). 2012 Jun;51(6):1086-92. doi: 10.1093/rheumatology/ker515. Epub 2012 Feb 3.

21.

Dysregulation of the microvasculature in nonlesional non-sun-exposed skin of patients with lupus nephritis.

Izmirly PM, Shvartsbeyn M, Meehan S, Franks A, Braun A, Ginzler E, Xu SX, Yee H, Rivera TL, Esmon C, Barisoni L, Merrill JT, Buyon JP, Clancy RM.

J Rheumatol. 2012 Mar;39(3):510-5. doi: 10.3899/jrheum.110878. Epub 2012 Feb 1. Erratum in: J Rheumatol. 2012 Apr;39(4):881. Rivera, Tania [corrected to Rivera, Tania L].

22.

Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.

Izmirly PM, Saxena A, Kim MY, Wang D, Sahl SK, Llanos C, Friedman D, Buyon JP.

Circulation. 2011 Nov 1;124(18):1927-35. doi: 10.1161/CIRCULATIONAHA.111.033894. Epub 2011 Oct 3.

23.

Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine.

Izmirly PM, Kim MY, Llanos C, Le PU, Guerra MM, Askanase AD, Salmon JE, Buyon JP.

Ann Rheum Dis. 2010 Oct;69(10):1827-30. doi: 10.1136/ard.2009.119263. Epub 2010 May 6.

24.

Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial.

Friedman DM, Llanos C, Izmirly PM, Brock B, Byron J, Copel J, Cummiskey K, Dooley MA, Foley J, Graves C, Hendershott C, Kates R, Komissarova EV, Miller M, Paré E, Phoon CK, Prosen T, Reisner D, Ruderman E, Samuels P, Yu JK, Kim MY, Buyon JP.

Arthritis Rheum. 2010 Apr;62(4):1138-46. doi: 10.1002/art.27308.

25.

Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block.

Izmirly PM, Llanos C, Lee LA, Askanase A, Kim MY, Buyon JP.

Arthritis Rheum. 2010 Apr;62(4):1153-7. doi: 10.1002/art.27333.

26.

Frequency of neuro-psychiatric dysfunction in anti-SSA/SSB exposed children with and without neonatal lupus.

Askanase AD, Izmirly PM, Katholi M, Mumtaz J, Buyon JP.

Lupus. 2010 Mar;19(3):300-6. doi: 10.1177/0961203309354542. Epub 2009 Dec 14.

PMID:
20008445
27.

Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors.

Llanos C, Izmirly PM, Katholi M, Clancy RM, Friedman DM, Kim MY, Buyon JP.

Arthritis Rheum. 2009 Oct;60(10):3091-7. doi: 10.1002/art.24768.

28.

Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis.

Izmirly PM, Barisoni L, Buyon JP, Kim MY, Rivera TL, Schwartzman JS, Weisstuch JM, Liu DT, Bernstein S, Tseng CE, Belmont HM, Esmon CT, Merrill JT, Askanase AD, Thomas DB, Clancy RM.

Rheumatology (Oxford). 2009 May;48(5):513-9. doi: 10.1093/rheumatology/kep034. Epub 2009 Mar 13.

29.

Use of pharmacogenetics, enzymatic phenotyping, and metabolite monitoring to guide treatment with azathioprine in patients with systemic lupus erythematosus.

Askanase AD, Wallace DJ, Weisman MH, Tseng CE, Bernstein L, Belmont HM, Seidman E, Ishimori M, Izmirly PM, Buyon JP.

J Rheumatol. 2009 Jan;36(1):89-95. doi: 10.3899/jrheum.070968.

PMID:
19040311
30.

Current therapies for lupus nephritis in an ethnically heterogeneous cohort.

Rivera TL, Belmont HM, Malani S, Latorre M, Benton L, Weisstuch J, Barisoni L, Tseng CE, Izmirly PM, Buyon JP, Askanase AD.

J Rheumatol. 2009 Feb;36(2):298-305. doi: 10.3899/jrheum.080335.

PMID:
19040310
31.

Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus.

Rivera TL, Izmirly PM, Birnbaum BK, Byrne P, Brauth JB, Katholi M, Kim MY, Fischer J, Clancy RM, Buyon JP.

Ann Rheum Dis. 2009 Jun;68(6):828-35. doi: 10.1136/ard.2008.088054. Epub 2008 Jul 14.

32.

Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic.

Mor A, Bingham CO 3rd, Kishimoto M, Izmirly PM, Greenberg JD, Reddy S, Rosenthal PB.

Ann Rheum Dis. 2008 Apr;67(4):462-5. Epub 2007 Aug 20.

PMID:
17711866
33.

Neonatal lupus syndromes.

Izmirly PM, Rivera TL, Buyon JP.

Rheum Dis Clin North Am. 2007 May;33(2):267-85, vi. Review.

PMID:
17499707

Supplemental Content

Loading ...
Support Center